Your browser doesn't support javascript.
loading
Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of Fallot.
Goldstein, Bryan H; Petit, Christopher J; Qureshi, Athar M; McCracken, Courtney E; Kelleman, Michael S; Nicholson, George T; Law, Mark A; Meadows, Jeffery J; Zampi, Jeffrey D; Shahanavaz, Shabana; Mascio, Christopher E; Chai, Paul J; Romano, Jennifer C; Batlivala, Sarosh P; Maskatia, Shiraz A; Asztalos, Ivor B; Kamsheh, Alicia M; Healan, Steven J; Smith, Justin D; Ligon, R Allen; Pettus, Joelle A; Juma, Sarina; Raulston, James E B; Hock, Krissie M; Pajk, Amy L; Eilers, Lindsay F; Khan, Hala Q; Merritt, Taylor C; Canter, Matthew; Juergensen, Stephan; Rinderknecht, Fatuma-Ayaan; Bauser-Heaton, Holly; Glatz, Andrew C.
Afiliación
  • Goldstein BH; Heart Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; The Heart Institute, Cincinnati Children's Hospital, Cincinnati, Ohio, USA; Department of Pediatrics, Universi
  • Petit CJ; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Qureshi AM; The Lillie Frank Abercrombie Section of Cardiology, Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • McCracken CE; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Kelleman MS; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Nicholson GT; Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville Tennessee, USA.
  • Law MA; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Meadows JJ; Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Zampi JD; University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.
  • Shahanavaz S; The Heart Center, St. Louis Children's Hospital, St. Louis, Missouri, USA.
  • Mascio CE; Cardiac Center at the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Chai PJ; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Romano JC; University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.
  • Batlivala SP; The Heart Institute, Cincinnati Children's Hospital, Cincinnati, Ohio, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Maskatia SA; Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital, Palo Alto, California, USA; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
  • Asztalos IB; Cardiac Center at the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kamsheh AM; Cardiac Center at the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Healan SJ; Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville Tennessee, USA.
  • Smith JD; University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.
  • Ligon RA; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Pettus JA; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Juma S; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Raulston JEB; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Hock KM; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Pajk AL; The Heart Institute, Cincinnati Children's Hospital, Cincinnati, Ohio, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Eilers LF; The Lillie Frank Abercrombie Section of Cardiology, Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Khan HQ; The Lillie Frank Abercrombie Section of Cardiology, Texas Children's Hospital, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Merritt TC; The Heart Center, St. Louis Children's Hospital, St. Louis, Missouri, USA.
  • Canter M; The Heart Center, St. Louis Children's Hospital, St. Louis, Missouri, USA.
  • Juergensen S; Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Rinderknecht FA; Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Bauser-Heaton H; Children's Heart Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Glatz AC; Cardiac Center at the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, US
J Am Coll Cardiol ; 77(8): 1093-1106, 2021 03 02.
Article en En | MEDLINE | ID: mdl-33632484
ABSTRACT

BACKGROUND:

Neonates with tetralogy of Fallot and symptomatic cyanosis (sTOF) require early intervention.

OBJECTIVES:

This study sought to perform a balanced multicenter comparison of staged repair (SR) (initial palliation [IP] and subsequent complete repair [CR]) versus primary repair (PR) treatment strategies.

METHODS:

Consecutive neonates with sTOF who underwent IP or PR at ≤30 days of age from 2005 to 2017 were retrospectively reviewed from the Congenital Cardiac Research Collaborative. The primary outcome was death. Secondary outcomes included component (IP, CR, PR) and cumulative (SR) hospital and intensive care unit lengths of stay; durations of cardiopulmonary bypass, anesthesia, ventilation, and inotrope use; and complication and reintervention rates. Outcomes were compared using propensity score adjustment.

RESULTS:

The cohort consisted of 342 patients who underwent SR (IP surgical, n = 256; transcatheter, n = 86) and 230 patients who underwent PR. Pre-procedural ventilation, prematurity, DiGeorge syndrome, and pulmonary atresia were more common in the SR group (p ≤0.01). The observed risk of death was not different between the groups (10.2% vs 7.4%; p = 0.25) at median 4.3 years. After adjustment, the hazard of death remained similar between groups (hazard ratio 0.82; 95% confidence interval 0.49 to 1.38; p = 0.456), but it favored SR during early follow-up (<4 months; p = 0.041). Secondary outcomes favored the SR group in component analysis, whereas they largely favored PR in cumulative analysis. Reintervention risk was higher in the SR group (p = 0.002).

CONCLUSIONS:

In this multicenter comparison of SR or PR for management of neonates with sTOF, adjusted for patient-related factors, early mortality and neonatal morbidity were lower in the SR group, but cumulative morbidity and reinterventions favored the PR group, findings suggesting potential benefits to each strategy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Tetralogía de Fallot Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans / Newborn Idioma: En Revista: J Am Coll Cardiol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Tetralogía de Fallot Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans / Newborn Idioma: En Revista: J Am Coll Cardiol Año: 2021 Tipo del documento: Article
...